Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma

Hansen, 2000, Retinoids in chemoprevention and differentiation therapy, Carcinogenesis, 21, 1271, 10.1093/carcin/21.7.1271 Lotan, 1996, Retinoids in cancer chemoprevention, FASEB J, 10, 1031, 10.1096/fasebj.10.9.8801164 Hong, 1994, The retinoids. Biology, Chemistry, and Medicine, 597 Muto, 1984, Antitumor activity of vitamin A and its derivatives, J Natl Cancer Inst, 73, 1389 Muto, 1996, Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma, N Engl J Med, 334, 1561, 10.1056/NEJM199606133342402 Muto, 1999, Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma, N Engl J Med, 340, 1046, 10.1056/NEJM199904013401315 Chambon, 1996, A decade of molecular biology of retinoic acid receptors, FASEB J, 10, 940, 10.1096/fasebj.10.9.8801176 Kastner, 1995, Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?, Cell, 83, 859, 10.1016/0092-8674(95)90202-3 Mangelsdorf, 1994, The Retinoids, 319 Mangelsdorf, 1995, The nuclear receptor superfamily: the second decade, Cell, 83, 835, 10.1016/0092-8674(95)90199-X Matsushima-Nishiwaki, 1996, Aberrant metabolism of retinoid X receptor proteins in human hepatocellular carcinoma, Mol Cell Endocrinol, 121, 179, 10.1016/0303-7207(96)03863-4 Matsushima-Nishiwaki, 1996, Limited degradation of retinoid X receptor by calpain, Biochem Biophys Res Commun, 225, 946, 10.1006/bbrc.1996.1276 Matsushima-Nishiwaki, 2001, Phosphorylation of retinoid X receptor α at serine 260 impairs its metabolism and function in human hepatocellular carcinoma, Cancer Res, 61, 7675 Joazeiro, 2000, RING finger proteins: mediators of ubiquitin ligase activity, Cell, 102, 549, 10.1016/S0092-8674(00)00077-5 Hershko, 1998, The ubiquitin system, Annu Rev Biochem, 67, 425, 10.1146/annurev.biochem.67.1.425 Murray, 1998, The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells, Exp Cell Res, 242, 460, 10.1006/excr.1998.4090 Nirmala, 1995, Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol, Biochem Biophys Res Commun, 213, 24, 10.1006/bbrc.1995.2093 Kumar, 1997, Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity, J Biol Chem, 272, 13548, 10.1074/jbc.272.21.13548 Laney, 1999, Substrate targeting in the ubiquitin system, Cell, 97, 427, 10.1016/S0092-8674(00)80752-7 Ivan, 2001, HIF α targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, 292, 464, 10.1126/science.1059817 Kopf, 2000, Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors α and γ through the ubiquitin-proteasome pathway, J Biol Chem, 275, 33280, 10.1074/jbc.M002840200 Dace, 2000, Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors, Proc Natl Acad Sci U S A, 97, 8985, 10.1073/pnas.160257997 Nawaz, 1999, Proteasome-dependent degradation of the human estrogen receptor, Proc Natl Acad Sci U S A, 96, 1858, 10.1073/pnas.96.5.1858 Boudjelal, 2000, Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor γ and retinoid X receptor α in human keratinocytes, Cancer Res, 60, 2247 Kimura, 1997, cDNA cloning, characterization, and chromosome mapping of UBE2E2 encoding a human ubiquitin-conjugating E2 enzyme, Cytogenet Cell Genet, 78, 107, 10.1159/000134639 Mansour, 1994, Transformation of mammalian cells by constitutively active MAP kinase kinase, Science, 265, 966, 10.1126/science.8052857 Mangelsdorf, 1991, A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR, Cell, 66, 555, 10.1016/0092-8674(81)90018-0 Treier, 1994, Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain, Cell, 78, 787, 10.1016/S0092-8674(94)90502-9 Lee, 1999, All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity, Mol Cell Biol, 19, 1973, 10.1128/MCB.19.3.1973 Rubinfeld, 1997, Stabilization of β-catenin by genetic defects in melanoma cell lines, Science, 275, 1790, 10.1126/science.275.5307.1790 Yaron, 1997, Inhibition of NF-κB cellular function via specific targeting of the I-κB-ubiquitin ligase, EMBO J, 16, 6486, 10.1093/emboj/16.21.6486 Okazaki, 1995, The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH3T3 cells, EMBO J, 14, 5048, 10.1002/j.1460-2075.1995.tb00187.x Nakamura, 1995, Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7, Biochem Biophys Res Commun, 207, 382, 10.1006/bbrc.1995.1199 Solomon, 1999, Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor α, J Clin Invest, 103, 1729, 10.1172/JCI6871 Solomon, 2001, Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies, Radiat Res, 155, 156, 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2